ArticleJTCVS open2026
Real-world performance of postpericardiotomy syndrome diagnostic criteria-An analysis of the prospective Cardiovascular Research Consortium-A Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients (CAREBANK) database.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Postpericardiotomy syndrome (PPS) is a well-recognized postoperative complication in cardiac surgery. Current diagnostic criteria, however, seem to lack specificity and fail to account for common confounding factors encountered in clinical settings. Methods: We examined the performance of current PPS diagnostic criteria in a prospective cohort of 1001 patients from the CAREBANK (Cardiovascular Research Consortium-A Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients) database who underwent cardiac surgery between 2016 and 2021 at a tertiary center. Considering clinical relevance together with the evaluation of coexisting confounding conditions, the patients fulfilling the criteria were divided into 4 categories: "definite PPS," "likely PPS," "unlikely PPS," and "no PPS." Results: The incidence of "definite PPS" and "likely PPS" was 4.0% each, whereas "unlikely PPS" and "no PPS" accounted for 8.7% and 83.3%, respectively. The median time to diagnosis was 42 days (interquartile range, 19-63) days for "definite PPS" and 24 days (9-49) days for "likely PPS." Patients categorized as "likely PPS" or "unlikely PPS" exhibited greater European System for Cardiac Operative Risk Evaluation II values, increased incidence of new-onset atrial fibrillation, delayed postoperative ventilation, and postoperative stroke, and elevated first-year mortality. Conclusions: Accurate diagnosis of PPS is often challenged by overlapping clinical conditions, especially in patients with multiple comorbidities. The majority of patients fulfilling current PPS diagnostic criteria have confounding explanations rather than genuine inflammatory disease. The presented 4-tier approach enhances the accuracy of distinguishing true inflammatory PPS and conditions that mimic its clinical presentation and should therefore be considered in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.